Health Canada approves Moderna's mRNA flu and flu-COVID vaccines
Health Canada has authorized Moderna's mRNA vaccine for influenza, as well as its combination mRNA vaccine for flu and COVID-19, according to The Canadian Press.
Both vaccines are approved for adults 50 years of age and older.
A spokesperson for Moderna said Health Canada notified the company that its flu vaccine, called mFLUSIVA, and its combination flu and COVID-19 shot, called mCOFLU, were approved on Thursday.
Moderna told The Canadian Press the vaccines will not hit pharmacies in time for this respiratory virus season.
In a news release, the company said its mRNA flu shot was approved in the United States in August and its combination vaccine was approved in Europe last April. It said Canada is the first country to authorize both of the vaccines.


